Figure 2 — 90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro

Research Paper|Volume 13, Issue 6|pp. 8355–8368

90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro

Back to articleFigure 2(2 of 7)

100%

Figure 2.The correlation between survival and 90K expression was analyzed. Data showed that higher 90K expression was associated with worse overall survival (OS) in patients with glioma (A, C) and GBM (B, D) based on TCGA and CGGA datasets.